Scancell Holdings plc (LON:SCLP - Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 13.76 ($0.17) and traded as low as GBX 9.50 ($0.12). Scancell shares last traded at GBX 10.10 ($0.12), with a volume of 844,442 shares trading hands.
Scancell Price Performance
The firm has a 50 day moving average price of GBX 12.24 and a two-hundred day moving average price of GBX 13.73. The company has a market cap of £93.89 million, a P/E ratio of -1,010.00 and a beta of 0.35. The company has a debt-to-equity ratio of 61.41, a quick ratio of 13.01 and a current ratio of 3.42.
Scancell Company Profile
(
Get Free Report)
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.
Read More
Before you consider Scancell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.
While Scancell currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
